Matches in SemOpenAlex for { <https://semopenalex.org/work/W2296926020> ?p ?o ?g. }
- W2296926020 endingPage "885" @default.
- W2296926020 startingPage "880" @default.
- W2296926020 abstract "The availability of monoclonal antibodies to tumor necrosis factor α has revolutionized management of Crohn's disease (CD) and ulcerative colitis. However, limited data exist regarding comparative effectiveness of these agents to inform clinical practice. This study consisted of patients with CD or ulcerative colitis initiation either infliximab (IFX) or adalimumab (ADA) between 1998 and 2010. A validated likelihood of nonresponse classification score using frequency of narrative mentions of relevant symptoms in the electronic health record was applied to assess comparative effectiveness at 1 year. Inflammatory bowel disease–related surgery, hospitalization, and use of steroids were determined during this period. Our final cohort included 1060 new initiations of IFX (68% for CD) and 391 of ADA (79% for CD). In CD, the likelihood of nonresponse was higher in ADA than IFX (odds ratio, 1.62 and 95% CI, 1.21–2.17). Similar differences favoring efficacy of IFX were observed for the individual symptoms of diarrhea, pain, bleeding, and fatigue. However, there was no difference in inflammatory bowel disease–related surgery, hospitalizations, or prednisone use within 1 year after initiation of IFX or ADA in CD. There was no difference in narrative or codified outcomes between the 2 agents in ulcerative colitis. We identified a modestly higher likelihood of symptomatic nonresponse at 1 year for ADA compared with IFX in patients with CD. However, there were no differences in inflammatory bowel disease–related surgery or hospitalizations, suggesting these treatments are broadly comparable in effectiveness in routine clinical practice." @default.
- W2296926020 created "2016-06-24" @default.
- W2296926020 creator A5025181406 @default.
- W2296926020 creator A5040074226 @default.
- W2296926020 creator A5047884465 @default.
- W2296926020 creator A5065574984 @default.
- W2296926020 creator A5073977144 @default.
- W2296926020 creator A5078003862 @default.
- W2296926020 creator A5082819294 @default.
- W2296926020 creator A5087242254 @default.
- W2296926020 creator A5087506527 @default.
- W2296926020 creator A5087865794 @default.
- W2296926020 creator A5088509061 @default.
- W2296926020 date "2016-04-01" @default.
- W2296926020 modified "2023-10-12" @default.
- W2296926020 title "Comparative Effectiveness of Infliximab and Adalimumab in Crohnʼs Disease and Ulcerative Colitis" @default.
- W2296926020 cites W1441560749 @default.
- W2296926020 cites W1857468674 @default.
- W2296926020 cites W1963591033 @default.
- W2296926020 cites W1964785646 @default.
- W2296926020 cites W1966474205 @default.
- W2296926020 cites W1982138247 @default.
- W2296926020 cites W1990475163 @default.
- W2296926020 cites W1991810959 @default.
- W2296926020 cites W2000445173 @default.
- W2296926020 cites W2006812737 @default.
- W2296926020 cites W2009841271 @default.
- W2296926020 cites W2010007856 @default.
- W2296926020 cites W2013592287 @default.
- W2296926020 cites W2020640954 @default.
- W2296926020 cites W2029286309 @default.
- W2296926020 cites W2049154391 @default.
- W2296926020 cites W2049827204 @default.
- W2296926020 cites W2056917411 @default.
- W2296926020 cites W2092863985 @default.
- W2296926020 cites W2096675088 @default.
- W2296926020 cites W2105311242 @default.
- W2296926020 cites W2109056977 @default.
- W2296926020 cites W2137775651 @default.
- W2296926020 cites W2146089916 @default.
- W2296926020 cites W2152026434 @default.
- W2296926020 cites W2168370388 @default.
- W2296926020 cites W2171297959 @default.
- W2296926020 cites W2171341132 @default.
- W2296926020 cites W2289033807 @default.
- W2296926020 cites W268488872 @default.
- W2296926020 doi "https://doi.org/10.1097/mib.0000000000000754" @default.
- W2296926020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4792716" @default.
- W2296926020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26933751" @default.
- W2296926020 hasPublicationYear "2016" @default.
- W2296926020 type Work @default.
- W2296926020 sameAs 2296926020 @default.
- W2296926020 citedByCount "44" @default.
- W2296926020 countsByYear W22969260202016 @default.
- W2296926020 countsByYear W22969260202017 @default.
- W2296926020 countsByYear W22969260202018 @default.
- W2296926020 countsByYear W22969260202019 @default.
- W2296926020 countsByYear W22969260202020 @default.
- W2296926020 countsByYear W22969260202021 @default.
- W2296926020 countsByYear W22969260202022 @default.
- W2296926020 countsByYear W22969260202023 @default.
- W2296926020 crossrefType "journal-article" @default.
- W2296926020 hasAuthorship W2296926020A5025181406 @default.
- W2296926020 hasAuthorship W2296926020A5040074226 @default.
- W2296926020 hasAuthorship W2296926020A5047884465 @default.
- W2296926020 hasAuthorship W2296926020A5065574984 @default.
- W2296926020 hasAuthorship W2296926020A5073977144 @default.
- W2296926020 hasAuthorship W2296926020A5078003862 @default.
- W2296926020 hasAuthorship W2296926020A5082819294 @default.
- W2296926020 hasAuthorship W2296926020A5087242254 @default.
- W2296926020 hasAuthorship W2296926020A5087506527 @default.
- W2296926020 hasAuthorship W2296926020A5087865794 @default.
- W2296926020 hasAuthorship W2296926020A5088509061 @default.
- W2296926020 hasBestOaLocation W22969260201 @default.
- W2296926020 hasConcept C126322002 @default.
- W2296926020 hasConcept C156957248 @default.
- W2296926020 hasConcept C2777138892 @default.
- W2296926020 hasConcept C2778260677 @default.
- W2296926020 hasConcept C2778720950 @default.
- W2296926020 hasConcept C2779134260 @default.
- W2296926020 hasConcept C2779280984 @default.
- W2296926020 hasConcept C2780132546 @default.
- W2296926020 hasConcept C2780479503 @default.
- W2296926020 hasConcept C71924100 @default.
- W2296926020 hasConcept C72563966 @default.
- W2296926020 hasConcept C90924648 @default.
- W2296926020 hasConceptScore W2296926020C126322002 @default.
- W2296926020 hasConceptScore W2296926020C156957248 @default.
- W2296926020 hasConceptScore W2296926020C2777138892 @default.
- W2296926020 hasConceptScore W2296926020C2778260677 @default.
- W2296926020 hasConceptScore W2296926020C2778720950 @default.
- W2296926020 hasConceptScore W2296926020C2779134260 @default.
- W2296926020 hasConceptScore W2296926020C2779280984 @default.
- W2296926020 hasConceptScore W2296926020C2780132546 @default.
- W2296926020 hasConceptScore W2296926020C2780479503 @default.
- W2296926020 hasConceptScore W2296926020C71924100 @default.
- W2296926020 hasConceptScore W2296926020C72563966 @default.
- W2296926020 hasConceptScore W2296926020C90924648 @default.